Results of surveillance programme aimed at early diagnosis of cutaneous melanoma in high risk Mediterranean subjects

European Journal of Dermatology

Volumn 13, Issue 5, 2003, Pages 482-486

  Carli, Paolo ^a   Balzi, Daniela ^b   De Giorgi, Vincenzo ^a   Massi, Daniela ^a   Palli, Domenico ^c   Chiarugi, Alessandra ^a   Nardini, Paolo ^a   Giannotti, Benvenuto ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b ASL   (Italy)

^c CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

Author keywords

Atypical nevi; Common nevi; Melanoma risk

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CARCINOMA IN SITU; COHORT ANALYSIS; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; ITALY; MALE; MELANOMA; NEVUS; PERIODIC MEDICAL EXAMINATION; PROGNOSIS;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; MEDITERRANEAN REGION; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; NEVUS; POPULATION SURVEILLANCE; REGISTRIES; RISK; SKIN NEOPLASMS;

EID: 0142215477     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Garbe C, Buttner P, Weis J, et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994; 102: 695-9.
2. Roush Ordlund JJ, Forget B, Gruber SB, Kirkwood JM. Independence of dysplastic nevi from total nevi in determining risk for non familial melanoma. Prev Med 1988; 17: 273-9.
3. Vinceti M, Bergomi M, Borciani N, Serra L, Vivoli G. Rising melanoma incidence in an Italian community from 1986 to 1997. Melanoma Research 1999; 9: 97-103.
4. Buiotti E, Balzi D, Barchielli A, Carli S, Crocetti E, Giovannetti L. Registro Tumori Toscano in Cancer Incidence in Five Continents vol. VII, Parkin DM, Whelon SL, Ferlay J, Raymond L, Young J (Eds.), IARC Sci. Publication n. 143, pgg. 526-529, Lyon.
5. Carli P, Biggeri A, Giannotti B. Malignant melonoma in Italy: risks associated with common and clinically atypical melanocytic nevi. J Am Acad Dermatol 1995; 32: 734-9.
6. Naldi L, Imberti GL, Parozzini F, Gallus S, LA Vecchia C. Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population. Cancer 2000; 88: 2703-10.
7. Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 1997; 277: 1439-44.
8. Elder DE, Murphy GF. Atlas of tumor pathology: Melanocytic tumors of the skin. Third series. Washington D.C.: Armed Forces Institute of Pathology; Rosai J ed., 1991.
9. Rhodes AR. Public education and cancer of the skin. What do people need to know about melanoma and nonmelanma skin cancer? Cancer 1995; 75: 613-36.
10. MacKie RM, McHenry P, Hale D. Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups. Lancet 1993; 341: 1618-20.
11. Masri GD, Clark WH, Guerry D 4th, Halpern A, Thompson CJ, Elder DE. Screening and surveillance of patients at high risk for malignant melanoma results in detection of earlier disease. J Am Acad Dermatol 1990; 22: 1042-8.
12. Kelly JW, Yeatmon JM, Regalia C, Mason G, Henham AP. A high incidence of melanoma found in patients with multiple dysplastic naevi by photographic surveillance. Med J Aust 1997; 167: 191-4.
13. Schneider JS, Moore DH, Sagebiel RW. Risk factors for melanoma incidence in prospective follow up. The importance of atypical (dyasplastic) nevi. Arch Dermatol 1994; 130: 1002-7.
14. Halpern AC, Guerry D 4th, Elder DE, Trock B, Synnestvedt M. A cohort study of melanoma in patients with dysplastic nevi. J Invest Dermatol 1993; 100: 346S-9S.
15. Burton RC, Coates MS, Hersey P, et al. An analysis of a melanoma epidemic. Int J Cancer 1993; 55: 765-70.
16. Slue W, Kopf AW, Rivers JK. Total-body photographs of dysplastic nevi. Arch Dermatol 1988; 124: 1239-43.
17. Kanzler MH, Mroz-Gernhard. Primary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview. J Am Acad Dermatol 2001; 45: 260-76.
18. Pehamberger H, Binder M, Steiner A, et al. In vivo epiluminescence microscopy: improvement of early diagnosis of melanoma. J Invest Dermatol 1993; 100: 356S-62S.
19. Stolz W, Schiffner R, Plillet L et al. Improvement of monitoring of melanocytic skin lesions with the use of a computerized acquisition and surveillance unit with a skin surface microscopic television camera. J Am Acad Dermatol 1996; 35: 202-7.
20. Kittler H, Pehamberger H, Wolff K, Binder M. Follow up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi and common nevi. J Am Acad Dermatol 2000; 43: 467-76.
21. Kittler H, Binder M. Risks and benefits of sequential imaging of melanocytic skin lesions in patients with multiple atypical nevi. Arch Dermatol 2001; 137: 1590-5.